nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A4—Clonidine—glaucoma	0.176	0.301	CbGbCtD
Levofloxacin—SLC22A6—Methazolamide—glaucoma	0.0783	0.134	CbGbCtD
Levofloxacin—SLC22A6—Acetazolamide—glaucoma	0.0626	0.107	CbGbCtD
Levofloxacin—CYP1A2—Betaxolol—glaucoma	0.0526	0.09	CbGbCtD
Levofloxacin—CYP3A4—Pilocarpine—glaucoma	0.0309	0.0529	CbGbCtD
Levofloxacin—ABCB1—Timolol—glaucoma	0.0297	0.0507	CbGbCtD
Levofloxacin—CYP1A2—Clonidine—glaucoma	0.0288	0.0493	CbGbCtD
Levofloxacin—ABCB1—Clonidine—glaucoma	0.0252	0.0431	CbGbCtD
Levofloxacin—CYP3A4—Brinzolamide—glaucoma	0.0243	0.0415	CbGbCtD
Levofloxacin—CYP3A4—Dorzolamide—glaucoma	0.0234	0.0401	CbGbCtD
Levofloxacin—CYP3A4—Methazolamide—glaucoma	0.0209	0.0358	CbGbCtD
Levofloxacin—CYP3A4—Acetazolamide—glaucoma	0.0167	0.0286	CbGbCtD
Levofloxacin—CYP3A4—Clonidine—glaucoma	0.0151	0.0258	CbGbCtD
Levofloxacin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.00163	0.588	CbGdCrCtD
Levofloxacin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.00114	0.412	CbGdCrCtD
Levofloxacin—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00102	0.041	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—ATOH7—glaucoma	0.000882	0.0355	CbGpPWpGaD
Levofloxacin—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.000746	0.03	CbGpPWpGaD
Levofloxacin—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.000741	0.0298	CbGpPWpGaD
Levofloxacin—SLC22A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.000707	0.0285	CbGpPWpGaD
Levofloxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000656	0.0264	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000592	0.0238	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000585	0.0236	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00054	0.0218	CbGpPWpGaD
Levofloxacin—SLC22A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000518	0.0208	CbGpPWpGaD
Levofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00045	0.0181	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000428	0.0172	CbGpPWpGaD
Levofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00041	0.0165	CbGpPWpGaD
Levofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000401	0.0161	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000398	0.016	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000395	0.0159	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—OPN4—glaucoma	0.000351	0.0141	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.000334	0.0135	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000332	0.0134	CbGpPWpGaD
Levofloxacin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000316	0.0127	CbGpPWpGaD
Levofloxacin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000309	0.0125	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000305	0.0123	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—PEX19—glaucoma	0.0003	0.0121	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000277	0.0111	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000266	0.0107	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000243	0.00978	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000235	0.00948	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000226	0.0091	CbGpPWpGaD
Levofloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000208	0.00838	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000202	0.00815	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000202	0.00815	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.0002	0.00807	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000195	0.00785	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000194	0.00783	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000188	0.00759	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000188	0.00758	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000182	0.00732	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000177	0.00714	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.00017	0.00685	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000168	0.00677	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000166	0.00669	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000165	0.00663	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000161	0.00647	CbGpPWpGaD
Levofloxacin—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000161	0.00647	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000156	0.00626	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000155	0.00624	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000155	0.00623	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000151	0.00607	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000151	0.00607	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000147	0.00593	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000145	0.00585	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000142	0.00571	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000142	0.0057	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RAB8A—glaucoma	0.000138	0.00557	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000135	0.00544	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000134	0.0054	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.00013	0.00524	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000126	0.00506	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000125	0.00504	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000124	0.00499	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—OPTN—glaucoma	0.00012	0.00483	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000119	0.00479	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000119	0.00478	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000115	0.00462	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000114	0.0046	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000113	0.00457	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000113	0.00457	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000111	0.00448	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000111	0.00448	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000111	0.00448	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00011	0.00444	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000109	0.0044	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000108	0.00437	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000106	0.00426	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000104	0.00419	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.88e-05	0.00398	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.7e-05	0.00391	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.57e-05	0.00385	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—FAS—glaucoma	9.31e-05	0.00375	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Clonidine—glaucoma	9.27e-05	0.000239	CcSEcCtD
Levofloxacin—Feeling abnormal—Brinzolamide—glaucoma	9.24e-05	0.000238	CcSEcCtD
Levofloxacin—Mental disorder—Betaxolol—glaucoma	9.24e-05	0.000238	CcSEcCtD
Levofloxacin—Constipation—Pilocarpine—glaucoma	9.22e-05	0.000238	CcSEcCtD
Levofloxacin—Pain—Pilocarpine—glaucoma	9.22e-05	0.000238	CcSEcCtD
Levofloxacin—Cough—Clonidine—glaucoma	9.21e-05	0.000237	CcSEcCtD
Levofloxacin—Dizziness—Apraclonidine—glaucoma	9.2e-05	0.000237	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.2e-05	0.0037	CbGpPWpGaD
Levofloxacin—Malnutrition—Betaxolol—glaucoma	9.18e-05	0.000237	CcSEcCtD
Levofloxacin—Erythema—Betaxolol—glaucoma	9.18e-05	0.000237	CcSEcCtD
Levofloxacin—Urticaria—Dorzolamide—glaucoma	9.06e-05	0.000234	CcSEcCtD
Levofloxacin—Epistaxis—Timolol—glaucoma	9.06e-05	0.000233	CcSEcCtD
Levofloxacin—Abdominal pain—Dorzolamide—glaucoma	9.02e-05	0.000232	CcSEcCtD
Levofloxacin—Body temperature increased—Dorzolamide—glaucoma	9.02e-05	0.000232	CcSEcCtD
Levofloxacin—Tension—Betaxolol—glaucoma	9.01e-05	0.000232	CcSEcCtD
Levofloxacin—Sinusitis—Timolol—glaucoma	9.01e-05	0.000232	CcSEcCtD
Levofloxacin—Dysgeusia—Betaxolol—glaucoma	8.99e-05	0.000232	CcSEcCtD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.99e-05	0.00362	CbGpPWpGaD
Levofloxacin—Arthralgia—Clonidine—glaucoma	8.98e-05	0.000231	CcSEcCtD
Levofloxacin—Chest pain—Clonidine—glaucoma	8.98e-05	0.000231	CcSEcCtD
Levofloxacin—Abdominal pain—Travoprost—glaucoma	8.98e-05	0.000231	CcSEcCtD
Levofloxacin—Agranulocytosis—Timolol—glaucoma	8.96e-05	0.000231	CcSEcCtD
Levofloxacin—Anxiety—Clonidine—glaucoma	8.95e-05	0.000231	CcSEcCtD
Levofloxacin—Asthenia—Acetazolamide—glaucoma	8.93e-05	0.00023	CcSEcCtD
Levofloxacin—Dizziness—Bimatoprost—glaucoma	8.92e-05	0.00023	CcSEcCtD
Levofloxacin—Nervousness—Betaxolol—glaucoma	8.92e-05	0.00023	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	8.92e-05	0.00023	CcSEcCtD
Levofloxacin—Urticaria—Brinzolamide—glaucoma	8.91e-05	0.00023	CcSEcCtD
Levofloxacin—Feeling abnormal—Pilocarpine—glaucoma	8.88e-05	0.000229	CcSEcCtD
Levofloxacin—Discomfort—Clonidine—glaucoma	8.87e-05	0.000229	CcSEcCtD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.87e-05	0.00357	CbGpPWpGaD
Levofloxacin—Vomiting—Apraclonidine—glaucoma	8.85e-05	0.000228	CcSEcCtD
Levofloxacin—Muscle spasms—Betaxolol—glaucoma	8.83e-05	0.000228	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Pilocarpine—glaucoma	8.82e-05	0.000227	CcSEcCtD
Levofloxacin—Hypersensitivity—Brimonidine—glaucoma	8.8e-05	0.000227	CcSEcCtD
Levofloxacin—Dry mouth—Clonidine—glaucoma	8.78e-05	0.000226	CcSEcCtD
Levofloxacin—Bradycardia—Timolol—glaucoma	8.77e-05	0.000226	CcSEcCtD
Levofloxacin—Dermatitis—Apraclonidine—glaucoma	8.77e-05	0.000226	CcSEcCtD
Levofloxacin—Headache—Apraclonidine—glaucoma	8.72e-05	0.000225	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—SLC6A1—glaucoma	8.69e-05	0.0035	CbGpPWpGaD
Levofloxacin—Confusional state—Clonidine—glaucoma	8.68e-05	0.000224	CcSEcCtD
Levofloxacin—Vision blurred—Betaxolol—glaucoma	8.66e-05	0.000223	CcSEcCtD
Levofloxacin—Rhinitis—Timolol—glaucoma	8.64e-05	0.000223	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	8.61e-05	0.00347	CbGpPWpGaD
Levofloxacin—Oedema—Clonidine—glaucoma	8.61e-05	0.000222	CcSEcCtD
Levofloxacin—Tremor—Betaxolol—glaucoma	8.6e-05	0.000222	CcSEcCtD
Levofloxacin—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.58e-05	0.00345	CbGpPWpGaD
Levofloxacin—Hallucination—Timolol—glaucoma	8.58e-05	0.000221	CcSEcCtD
Levofloxacin—Asthenia—Brimonidine—glaucoma	8.57e-05	0.000221	CcSEcCtD
Levofloxacin—Infection—Clonidine—glaucoma	8.55e-05	0.00022	CcSEcCtD
Levofloxacin—Abdominal pain—Pilocarpine—glaucoma	8.52e-05	0.00022	CcSEcCtD
Levofloxacin—Body temperature increased—Pilocarpine—glaucoma	8.52e-05	0.00022	CcSEcCtD
Levofloxacin—Ill-defined disorder—Betaxolol—glaucoma	8.52e-05	0.00022	CcSEcCtD
Levofloxacin—Diarrhoea—Acetazolamide—glaucoma	8.52e-05	0.00022	CcSEcCtD
Levofloxacin—Rash—Bimatoprost—glaucoma	8.51e-05	0.000219	CcSEcCtD
Levofloxacin—Dermatitis—Bimatoprost—glaucoma	8.5e-05	0.000219	CcSEcCtD
Levofloxacin—Oedema peripheral—Timolol—glaucoma	8.49e-05	0.000219	CcSEcCtD
Levofloxacin—Anaemia—Betaxolol—glaucoma	8.49e-05	0.000219	CcSEcCtD
Levofloxacin—Shock—Clonidine—glaucoma	8.47e-05	0.000218	CcSEcCtD
Levofloxacin—Connective tissue disorder—Timolol—glaucoma	8.47e-05	0.000218	CcSEcCtD
Levofloxacin—Pruritus—Brimonidine—glaucoma	8.45e-05	0.000218	CcSEcCtD
Levofloxacin—Headache—Bimatoprost—glaucoma	8.45e-05	0.000218	CcSEcCtD
Levofloxacin—Nervous system disorder—Clonidine—glaucoma	8.44e-05	0.000218	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	8.44e-05	0.0034	CbGpPWpGaD
Levofloxacin—Thrombocytopenia—Clonidine—glaucoma	8.43e-05	0.000217	CcSEcCtD
Levofloxacin—Hypersensitivity—Dorzolamide—glaucoma	8.41e-05	0.000217	CcSEcCtD
Levofloxacin—Tachycardia—Clonidine—glaucoma	8.4e-05	0.000217	CcSEcCtD
Levofloxacin—Hypersensitivity—Travoprost—glaucoma	8.37e-05	0.000216	CcSEcCtD
Levofloxacin—Skin disorder—Clonidine—glaucoma	8.36e-05	0.000216	CcSEcCtD
Levofloxacin—Hyperhidrosis—Clonidine—glaucoma	8.32e-05	0.000215	CcSEcCtD
Levofloxacin—Visual impairment—Timolol—glaucoma	8.31e-05	0.000214	CcSEcCtD
Levofloxacin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	8.3e-05	0.00334	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.3e-05	0.00334	CbGpPWpGaD
Levofloxacin—Malaise—Betaxolol—glaucoma	8.28e-05	0.000213	CcSEcCtD
Levofloxacin—Nausea—Apraclonidine—glaucoma	8.27e-05	0.000213	CcSEcCtD
Levofloxacin—Hypersensitivity—Brinzolamide—glaucoma	8.26e-05	0.000213	CcSEcCtD
Levofloxacin—Vertigo—Betaxolol—glaucoma	8.25e-05	0.000213	CcSEcCtD
Levofloxacin—Syncope—Betaxolol—glaucoma	8.24e-05	0.000212	CcSEcCtD
Levofloxacin—Dizziness—Acetazolamide—glaucoma	8.23e-05	0.000212	CcSEcCtD
Levofloxacin—Anorexia—Clonidine—glaucoma	8.21e-05	0.000212	CcSEcCtD
Levofloxacin—Asthenia—Dorzolamide—glaucoma	8.19e-05	0.000211	CcSEcCtD
Levofloxacin—Asthenia—Travoprost—glaucoma	8.15e-05	0.00021	CcSEcCtD
Levofloxacin—Palpitations—Betaxolol—glaucoma	8.12e-05	0.000209	CcSEcCtD
Levofloxacin—Pruritus—Dorzolamide—glaucoma	8.07e-05	0.000208	CcSEcCtD
Levofloxacin—Loss of consciousness—Betaxolol—glaucoma	8.07e-05	0.000208	CcSEcCtD
Levofloxacin—Eye disorder—Timolol—glaucoma	8.05e-05	0.000208	CcSEcCtD
Levofloxacin—Asthenia—Brinzolamide—glaucoma	8.05e-05	0.000207	CcSEcCtD
Levofloxacin—Hypotension—Clonidine—glaucoma	8.05e-05	0.000207	CcSEcCtD
Levofloxacin—Pruritus—Travoprost—glaucoma	8.04e-05	0.000207	CcSEcCtD
Levofloxacin—Tinnitus—Timolol—glaucoma	8.04e-05	0.000207	CcSEcCtD
Levofloxacin—Cough—Betaxolol—glaucoma	8.01e-05	0.000207	CcSEcCtD
Levofloxacin—Nausea—Bimatoprost—glaucoma	8.01e-05	0.000207	CcSEcCtD
Levofloxacin—Cardiac disorder—Timolol—glaucoma	8e-05	0.000206	CcSEcCtD
Levofloxacin—Hypersensitivity—Pilocarpine—glaucoma	7.94e-05	0.000205	CcSEcCtD
Levofloxacin—Pruritus—Brinzolamide—glaucoma	7.94e-05	0.000205	CcSEcCtD
Levofloxacin—Vomiting—Acetazolamide—glaucoma	7.91e-05	0.000204	CcSEcCtD
Levofloxacin—Dizziness—Brimonidine—glaucoma	7.9e-05	0.000204	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Clonidine—glaucoma	7.84e-05	0.000202	CcSEcCtD
Levofloxacin—Angiopathy—Timolol—glaucoma	7.82e-05	0.000202	CcSEcCtD
Levofloxacin—Chest pain—Betaxolol—glaucoma	7.82e-05	0.000202	CcSEcCtD
Levofloxacin—Arthralgia—Betaxolol—glaucoma	7.82e-05	0.000202	CcSEcCtD
Levofloxacin—Myalgia—Betaxolol—glaucoma	7.82e-05	0.000202	CcSEcCtD
Levofloxacin—Diarrhoea—Dorzolamide—glaucoma	7.81e-05	0.000201	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CA5A—glaucoma	7.81e-05	0.00314	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NARFL—glaucoma	7.81e-05	0.00314	CbGpPWpGaD
Levofloxacin—Headache—Acetazolamide—glaucoma	7.8e-05	0.000201	CcSEcCtD
Levofloxacin—Anxiety—Betaxolol—glaucoma	7.79e-05	0.000201	CcSEcCtD
Levofloxacin—Insomnia—Clonidine—glaucoma	7.79e-05	0.000201	CcSEcCtD
Levofloxacin—Immune system disorder—Timolol—glaucoma	7.79e-05	0.000201	CcSEcCtD
Levofloxacin—Diarrhoea—Travoprost—glaucoma	7.77e-05	0.0002	CcSEcCtD
Levofloxacin—Mediastinal disorder—Timolol—glaucoma	7.77e-05	0.0002	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	7.77e-05	0.0002	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	7.74e-05	0.00312	CbGpPWpGaD
Levofloxacin—Asthenia—Pilocarpine—glaucoma	7.74e-05	0.000199	CcSEcCtD
Levofloxacin—Paraesthesia—Clonidine—glaucoma	7.73e-05	0.000199	CcSEcCtD
Levofloxacin—Discomfort—Betaxolol—glaucoma	7.73e-05	0.000199	CcSEcCtD
Levofloxacin—Arrhythmia—Timolol—glaucoma	7.7e-05	0.000198	CcSEcCtD
Levofloxacin—Dyspnoea—Clonidine—glaucoma	7.68e-05	0.000198	CcSEcCtD
Levofloxacin—Diarrhoea—Brinzolamide—glaucoma	7.67e-05	0.000198	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.66e-05	0.00309	CbGpPWpGaD
Levofloxacin—Somnolence—Clonidine—glaucoma	7.65e-05	0.000197	CcSEcCtD
Levofloxacin—Dry mouth—Betaxolol—glaucoma	7.65e-05	0.000197	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	7.63e-05	0.00307	CbGpPWpGaD
Levofloxacin—Pruritus—Pilocarpine—glaucoma	7.63e-05	0.000197	CcSEcCtD
Levofloxacin—Alopecia—Timolol—glaucoma	7.62e-05	0.000196	CcSEcCtD
Levofloxacin—Confusional state—Betaxolol—glaucoma	7.56e-05	0.000195	CcSEcCtD
Levofloxacin—Mental disorder—Timolol—glaucoma	7.55e-05	0.000195	CcSEcCtD
Levofloxacin—Dizziness—Dorzolamide—glaucoma	7.55e-05	0.000194	CcSEcCtD
Levofloxacin—Rash—Brimonidine—glaucoma	7.53e-05	0.000194	CcSEcCtD
Levofloxacin—Dermatitis—Brimonidine—glaucoma	7.53e-05	0.000194	CcSEcCtD
Levofloxacin—Dizziness—Travoprost—glaucoma	7.51e-05	0.000194	CcSEcCtD
Levofloxacin—Malnutrition—Timolol—glaucoma	7.5e-05	0.000193	CcSEcCtD
Levofloxacin—Erythema—Timolol—glaucoma	7.5e-05	0.000193	CcSEcCtD
Levofloxacin—Oedema—Betaxolol—glaucoma	7.5e-05	0.000193	CcSEcCtD
Levofloxacin—Headache—Brimonidine—glaucoma	7.48e-05	0.000193	CcSEcCtD
Levofloxacin—Decreased appetite—Clonidine—glaucoma	7.48e-05	0.000193	CcSEcCtD
Levofloxacin—Infection—Betaxolol—glaucoma	7.45e-05	0.000192	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Clonidine—glaucoma	7.43e-05	0.000192	CcSEcCtD
Levofloxacin—Fatigue—Clonidine—glaucoma	7.42e-05	0.000191	CcSEcCtD
Levofloxacin—Dizziness—Brinzolamide—glaucoma	7.42e-05	0.000191	CcSEcCtD
Levofloxacin—Nausea—Acetazolamide—glaucoma	7.39e-05	0.000191	CcSEcCtD
Levofloxacin—Diarrhoea—Pilocarpine—glaucoma	7.38e-05	0.00019	CcSEcCtD
Levofloxacin—Shock—Betaxolol—glaucoma	7.37e-05	0.00019	CcSEcCtD
Levofloxacin—Tension—Timolol—glaucoma	7.36e-05	0.00019	CcSEcCtD
Levofloxacin—Constipation—Clonidine—glaucoma	7.36e-05	0.00019	CcSEcCtD
Levofloxacin—Pain—Clonidine—glaucoma	7.36e-05	0.00019	CcSEcCtD
Levofloxacin—Nervous system disorder—Betaxolol—glaucoma	7.35e-05	0.000189	CcSEcCtD
Levofloxacin—Dysgeusia—Timolol—glaucoma	7.35e-05	0.000189	CcSEcCtD
Levofloxacin—Thrombocytopenia—Betaxolol—glaucoma	7.34e-05	0.000189	CcSEcCtD
Levofloxacin—Tachycardia—Betaxolol—glaucoma	7.32e-05	0.000189	CcSEcCtD
Levofloxacin—Nervousness—Timolol—glaucoma	7.29e-05	0.000188	CcSEcCtD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.29e-05	0.00293	CbGpPWpGaD
Levofloxacin—Skin disorder—Betaxolol—glaucoma	7.28e-05	0.000188	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—IL1A—glaucoma	7.26e-05	0.00293	CbGpPWpGaD
Levofloxacin—Vomiting—Dorzolamide—glaucoma	7.25e-05	0.000187	CcSEcCtD
Levofloxacin—Hyperhidrosis—Betaxolol—glaucoma	7.25e-05	0.000187	CcSEcCtD
Levofloxacin—Rash—Dorzolamide—glaucoma	7.19e-05	0.000185	CcSEcCtD
Levofloxacin—Dermatitis—Dorzolamide—glaucoma	7.19e-05	0.000185	CcSEcCtD
Levofloxacin—Rash—Travoprost—glaucoma	7.16e-05	0.000185	CcSEcCtD
Levofloxacin—Dermatitis—Travoprost—glaucoma	7.16e-05	0.000184	CcSEcCtD
Levofloxacin—Headache—Dorzolamide—glaucoma	7.15e-05	0.000184	CcSEcCtD
Levofloxacin—Anorexia—Betaxolol—glaucoma	7.14e-05	0.000184	CcSEcCtD
Levofloxacin—Vomiting—Brinzolamide—glaucoma	7.13e-05	0.000184	CcSEcCtD
Levofloxacin—Dizziness—Pilocarpine—glaucoma	7.13e-05	0.000184	CcSEcCtD
Levofloxacin—Headache—Travoprost—glaucoma	7.12e-05	0.000183	CcSEcCtD
Levofloxacin—Nausea—Brimonidine—glaucoma	7.1e-05	0.000183	CcSEcCtD
Levofloxacin—Feeling abnormal—Clonidine—glaucoma	7.09e-05	0.000183	CcSEcCtD
Levofloxacin—Rash—Brinzolamide—glaucoma	7.07e-05	0.000182	CcSEcCtD
Levofloxacin—Vision blurred—Timolol—glaucoma	7.07e-05	0.000182	CcSEcCtD
Levofloxacin—Dermatitis—Brinzolamide—glaucoma	7.07e-05	0.000182	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Clonidine—glaucoma	7.04e-05	0.000181	CcSEcCtD
Levofloxacin—Headache—Brinzolamide—glaucoma	7.03e-05	0.000181	CcSEcCtD
Levofloxacin—Hypotension—Betaxolol—glaucoma	7e-05	0.000181	CcSEcCtD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.94e-05	0.00279	CbGpPWpGaD
Levofloxacin—Angioedema—Timolol—glaucoma	6.86e-05	0.000177	CcSEcCtD
Levofloxacin—Vomiting—Pilocarpine—glaucoma	6.85e-05	0.000177	CcSEcCtD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.85e-05	0.00276	CbGpPWpGaD
Levofloxacin—Urticaria—Clonidine—glaucoma	6.84e-05	0.000176	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Betaxolol—glaucoma	6.83e-05	0.000176	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	6.81e-05	0.00274	CbGpPWpGaD
Levofloxacin—Abdominal pain—Clonidine—glaucoma	6.81e-05	0.000175	CcSEcCtD
Levofloxacin—Body temperature increased—Clonidine—glaucoma	6.81e-05	0.000175	CcSEcCtD
Levofloxacin—Rash—Pilocarpine—glaucoma	6.8e-05	0.000175	CcSEcCtD
Levofloxacin—Dermatitis—Pilocarpine—glaucoma	6.79e-05	0.000175	CcSEcCtD
Levofloxacin—Insomnia—Betaxolol—glaucoma	6.78e-05	0.000175	CcSEcCtD
Levofloxacin—Nausea—Dorzolamide—glaucoma	6.78e-05	0.000175	CcSEcCtD
Levofloxacin—Headache—Pilocarpine—glaucoma	6.75e-05	0.000174	CcSEcCtD
Levofloxacin—Nausea—Travoprost—glaucoma	6.75e-05	0.000174	CcSEcCtD
Levofloxacin—Vertigo—Timolol—glaucoma	6.74e-05	0.000174	CcSEcCtD
Levofloxacin—Paraesthesia—Betaxolol—glaucoma	6.73e-05	0.000173	CcSEcCtD
Levofloxacin—Syncope—Timolol—glaucoma	6.73e-05	0.000173	CcSEcCtD
Levofloxacin—Dyspnoea—Betaxolol—glaucoma	6.68e-05	0.000172	CcSEcCtD
Levofloxacin—Nausea—Brinzolamide—glaucoma	6.66e-05	0.000172	CcSEcCtD
Levofloxacin—Palpitations—Timolol—glaucoma	6.63e-05	0.000171	CcSEcCtD
Levofloxacin—Dyspepsia—Betaxolol—glaucoma	6.6e-05	0.00017	CcSEcCtD
Levofloxacin—Loss of consciousness—Timolol—glaucoma	6.59e-05	0.00017	CcSEcCtD
Levofloxacin—Cough—Timolol—glaucoma	6.55e-05	0.000169	CcSEcCtD
Levofloxacin—Decreased appetite—Betaxolol—glaucoma	6.52e-05	0.000168	CcSEcCtD
Levofloxacin—Hypertension—Timolol—glaucoma	6.48e-05	0.000167	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—FAS—glaucoma	6.47e-05	0.00261	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Betaxolol—glaucoma	6.47e-05	0.000167	CcSEcCtD
Levofloxacin—Fatigue—Betaxolol—glaucoma	6.46e-05	0.000167	CcSEcCtD
Levofloxacin—Pain—Betaxolol—glaucoma	6.41e-05	0.000165	CcSEcCtD
Levofloxacin—Constipation—Betaxolol—glaucoma	6.41e-05	0.000165	CcSEcCtD
Levofloxacin—Nausea—Pilocarpine—glaucoma	6.4e-05	0.000165	CcSEcCtD
Levofloxacin—Arthralgia—Timolol—glaucoma	6.39e-05	0.000165	CcSEcCtD
Levofloxacin—Chest pain—Timolol—glaucoma	6.39e-05	0.000165	CcSEcCtD
Levofloxacin—Myalgia—Timolol—glaucoma	6.39e-05	0.000165	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.39e-05	0.00257	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—C3—glaucoma	6.38e-05	0.00257	CbGpPWpGaD
Levofloxacin—Anxiety—Timolol—glaucoma	6.37e-05	0.000164	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.34e-05	0.000164	CcSEcCtD
Levofloxacin—Hypersensitivity—Clonidine—glaucoma	6.34e-05	0.000163	CcSEcCtD
Levofloxacin—Discomfort—Timolol—glaucoma	6.31e-05	0.000163	CcSEcCtD
Levofloxacin—Dry mouth—Timolol—glaucoma	6.25e-05	0.000161	CcSEcCtD
Levofloxacin—Asthenia—Clonidine—glaucoma	6.18e-05	0.000159	CcSEcCtD
Levofloxacin—Feeling abnormal—Betaxolol—glaucoma	6.18e-05	0.000159	CcSEcCtD
Levofloxacin—Confusional state—Timolol—glaucoma	6.17e-05	0.000159	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	6.16e-05	0.00248	CbGpPWpGaD
Levofloxacin—Anaphylactic shock—Timolol—glaucoma	6.12e-05	0.000158	CcSEcCtD
Levofloxacin—Oedema—Timolol—glaucoma	6.12e-05	0.000158	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.1e-05	0.00246	CbGpPWpGaD
Levofloxacin—Pruritus—Clonidine—glaucoma	6.09e-05	0.000157	CcSEcCtD
Levofloxacin—Infection—Timolol—glaucoma	6.08e-05	0.000157	CcSEcCtD
Levofloxacin—Shock—Timolol—glaucoma	6.02e-05	0.000155	CcSEcCtD
Levofloxacin—Nervous system disorder—Timolol—glaucoma	6.01e-05	0.000155	CcSEcCtD
Levofloxacin—Urticaria—Betaxolol—glaucoma	5.95e-05	0.000153	CcSEcCtD
Levofloxacin—Skin disorder—Timolol—glaucoma	5.95e-05	0.000153	CcSEcCtD
Levofloxacin—Body temperature increased—Betaxolol—glaucoma	5.93e-05	0.000153	CcSEcCtD
Levofloxacin—Hyperhidrosis—Timolol—glaucoma	5.92e-05	0.000153	CcSEcCtD
Levofloxacin—Diarrhoea—Clonidine—glaucoma	5.89e-05	0.000152	CcSEcCtD
Levofloxacin—Anorexia—Timolol—glaucoma	5.84e-05	0.00015	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.78e-05	0.00233	CbGpPWpGaD
Levofloxacin—Hypotension—Timolol—glaucoma	5.72e-05	0.000147	CcSEcCtD
Levofloxacin—Dizziness—Clonidine—glaucoma	5.69e-05	0.000147	CcSEcCtD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.65e-05	0.00228	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.62e-05	0.00226	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.61e-05	0.00226	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Timolol—glaucoma	5.58e-05	0.000144	CcSEcCtD
Levofloxacin—Insomnia—Timolol—glaucoma	5.54e-05	0.000143	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.52e-05	0.00222	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Betaxolol—glaucoma	5.52e-05	0.000142	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CCND2—glaucoma	5.51e-05	0.00222	CbGpPWpGaD
Levofloxacin—Paraesthesia—Timolol—glaucoma	5.5e-05	0.000142	CcSEcCtD
Levofloxacin—Vomiting—Clonidine—glaucoma	5.47e-05	0.000141	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.47e-05	0.0022	CbGpPWpGaD
Levofloxacin—Dyspnoea—Timolol—glaucoma	5.46e-05	0.000141	CcSEcCtD
Levofloxacin—Somnolence—Timolol—glaucoma	5.44e-05	0.00014	CcSEcCtD
Levofloxacin—Rash—Clonidine—glaucoma	5.43e-05	0.00014	CcSEcCtD
Levofloxacin—Dermatitis—Clonidine—glaucoma	5.42e-05	0.00014	CcSEcCtD
Levofloxacin—Headache—Clonidine—glaucoma	5.39e-05	0.000139	CcSEcCtD
Levofloxacin—Dyspepsia—Timolol—glaucoma	5.39e-05	0.000139	CcSEcCtD
Levofloxacin—Asthenia—Betaxolol—glaucoma	5.38e-05	0.000139	CcSEcCtD
Levofloxacin—Decreased appetite—Timolol—glaucoma	5.32e-05	0.000137	CcSEcCtD
Levofloxacin—Pruritus—Betaxolol—glaucoma	5.3e-05	0.000137	CcSEcCtD
Levofloxacin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.29e-05	0.00213	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Timolol—glaucoma	5.29e-05	0.000136	CcSEcCtD
Levofloxacin—Fatigue—Timolol—glaucoma	5.28e-05	0.000136	CcSEcCtD
Levofloxacin—Pain—Timolol—glaucoma	5.24e-05	0.000135	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.23e-05	0.00211	CbGpPWpGaD
Levofloxacin—Diarrhoea—Betaxolol—glaucoma	5.13e-05	0.000132	CcSEcCtD
Levofloxacin—Nausea—Clonidine—glaucoma	5.11e-05	0.000132	CcSEcCtD
Levofloxacin—Feeling abnormal—Timolol—glaucoma	5.05e-05	0.00013	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	5.01e-05	0.00202	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Timolol—glaucoma	5.01e-05	0.000129	CcSEcCtD
Levofloxacin—Dizziness—Betaxolol—glaucoma	4.96e-05	0.000128	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CDKN2B—glaucoma	4.94e-05	0.00199	CbGpPWpGaD
Levofloxacin—Urticaria—Timolol—glaucoma	4.86e-05	0.000125	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.86e-05	0.00196	CbGpPWpGaD
Levofloxacin—Body temperature increased—Timolol—glaucoma	4.84e-05	0.000125	CcSEcCtD
Levofloxacin—Abdominal pain—Timolol—glaucoma	4.84e-05	0.000125	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.81e-05	0.00194	CbGpPWpGaD
Levofloxacin—Vomiting—Betaxolol—glaucoma	4.77e-05	0.000123	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.75e-05	0.00191	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.75e-05	0.00191	CbGpPWpGaD
Levofloxacin—Rash—Betaxolol—glaucoma	4.73e-05	0.000122	CcSEcCtD
Levofloxacin—Dermatitis—Betaxolol—glaucoma	4.72e-05	0.000122	CcSEcCtD
Levofloxacin—Headache—Betaxolol—glaucoma	4.7e-05	0.000121	CcSEcCtD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.69e-05	0.00189	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.67e-05	0.00188	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Timolol—glaucoma	4.51e-05	0.000116	CcSEcCtD
Levofloxacin—Nausea—Betaxolol—glaucoma	4.45e-05	0.000115	CcSEcCtD
Levofloxacin—Asthenia—Timolol—glaucoma	4.39e-05	0.000113	CcSEcCtD
Levofloxacin—Pruritus—Timolol—glaucoma	4.33e-05	0.000112	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—NARFL—glaucoma	4.26e-05	0.00172	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA5A—glaucoma	4.26e-05	0.00172	CbGpPWpGaD
Levofloxacin—Diarrhoea—Timolol—glaucoma	4.19e-05	0.000108	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.12e-05	0.00166	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.08e-05	0.00164	CbGpPWpGaD
Levofloxacin—Dizziness—Timolol—glaucoma	4.05e-05	0.000104	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.95e-05	0.00159	CbGpPWpGaD
Levofloxacin—Vomiting—Timolol—glaucoma	3.89e-05	0.0001	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.87e-05	0.00156	CbGpPWpGaD
Levofloxacin—Rash—Timolol—glaucoma	3.86e-05	9.95e-05	CcSEcCtD
Levofloxacin—Dermatitis—Timolol—glaucoma	3.86e-05	9.94e-05	CcSEcCtD
Levofloxacin—Headache—Timolol—glaucoma	3.84e-05	9.89e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.82e-05	0.00154	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA1—glaucoma	3.81e-05	0.00154	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.76e-05	0.00151	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.75e-05	0.00151	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.73e-05	0.0015	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.7e-05	0.00149	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CTSA—glaucoma	3.69e-05	0.00149	CbGpPWpGaD
Levofloxacin—Nausea—Timolol—glaucoma	3.64e-05	9.37e-05	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.63e-05	0.00146	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.62e-05	0.00146	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.49e-05	0.00141	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA2—glaucoma	3.49e-05	0.0014	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—glaucoma	3.49e-05	0.0014	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NARFL—glaucoma	3.4e-05	0.00137	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA5A—glaucoma	3.4e-05	0.00137	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.38e-05	0.00136	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.38e-05	0.00136	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.21e-05	0.00129	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.19e-05	0.00129	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	3.16e-05	0.00127	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.09e-05	0.00125	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.05e-05	0.00123	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.99e-05	0.0012	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.95e-05	0.00119	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2A—glaucoma	2.82e-05	0.00114	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.8e-05	0.00113	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TNF—glaucoma	2.75e-05	0.00111	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.73e-05	0.0011	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NARFL—glaucoma	2.63e-05	0.00106	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA5A—glaucoma	2.63e-05	0.00106	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.55e-05	0.00103	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1B—glaucoma	2.5e-05	0.00101	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TXN—glaucoma	2.46e-05	0.000989	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.39e-05	0.000962	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.36e-05	0.000948	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA1—glaucoma	2.08e-05	0.000839	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CTSA—glaucoma	2.02e-05	0.000812	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.01e-05	0.000809	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA2—glaucoma	1.9e-05	0.000767	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—glaucoma	1.9e-05	0.000767	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.9e-05	0.000766	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA1—glaucoma	1.66e-05	0.00067	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CTSA—glaucoma	1.61e-05	0.000648	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.58e-05	0.000637	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—glaucoma	1.57e-05	0.000633	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA2—glaucoma	1.52e-05	0.000612	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCA1—glaucoma	1.52e-05	0.000611	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1B1—glaucoma	1.52e-05	0.000611	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.49e-05	0.000598	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.49e-05	0.000598	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.36e-05	0.000546	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TXN—glaucoma	1.34e-05	0.00054	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA1—glaucoma	1.28e-05	0.000517	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CTSA—glaucoma	1.24e-05	0.0005	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTM1—glaucoma	1.21e-05	0.000489	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.2e-05	0.000482	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA2—glaucoma	1.17e-05	0.000473	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—MTHFR—glaucoma	1.07e-05	0.000432	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TXN—glaucoma	1.07e-05	0.000431	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—glaucoma	1.04e-05	0.000419	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APOE—glaucoma	9.98e-06	0.000402	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAV1—glaucoma	9.89e-06	0.000398	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.78e-06	0.000394	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.69e-06	0.00039	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—glaucoma	8.31e-06	0.000335	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1B1—glaucoma	8.29e-06	0.000334	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ABCA1—glaucoma	8.29e-06	0.000334	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TXN—glaucoma	8.27e-06	0.000333	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NOS3—glaucoma	7.48e-06	0.000301	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—glaucoma	6.84e-06	0.000275	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.7e-06	0.00027	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—glaucoma	6.63e-06	0.000267	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1B1—glaucoma	6.62e-06	0.000267	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCA1—glaucoma	6.62e-06	0.000267	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—glaucoma	6.41e-06	0.000258	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MTHFR—glaucoma	5.86e-06	0.000236	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APOE—glaucoma	5.45e-06	0.00022	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAV1—glaucoma	5.4e-06	0.000218	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—glaucoma	5.29e-06	0.000213	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1B1—glaucoma	5.11e-06	0.000206	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCA1—glaucoma	5.11e-06	0.000206	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—MTHFR—glaucoma	4.68e-06	0.000188	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APOE—glaucoma	4.35e-06	0.000175	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAV1—glaucoma	4.31e-06	0.000174	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NOS3—glaucoma	4.09e-06	0.000165	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—glaucoma	4.08e-06	0.000164	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—glaucoma	3.74e-06	0.00015	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MTHFR—glaucoma	3.61e-06	0.000145	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APOE—glaucoma	3.36e-06	0.000135	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAV1—glaucoma	3.33e-06	0.000134	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NOS3—glaucoma	3.26e-06	0.000131	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—glaucoma	2.98e-06	0.00012	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NOS3—glaucoma	2.52e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—glaucoma	2.3e-06	9.27e-05	CbGpPWpGaD
